EUVIMEDEUVIMED entdecken
Crossref

Dual‐Drug Loaded γ‐Polyglutamic Acid Hydrogel with Hydrophilic Doxorubicin and Hydrophobic Camptothecin for Enhanced Tumor Therapy

Xiaoqing Jia, Yingfeng Wei, Xinyuan Zhang, Qiuping Gu, Youshun Liu, Shige Wang iD, Chunping Zhu

Chemistry – An Asian Journal · 2025

DOI: 10.1002/asia.202500058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry – An Asian Journal, 2025. Verfasst von Xiaoqing Jia und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Materials and Chemistry, University of Shanghai for Science and Technology, No. 516 Jungong Road, Shanghai, 200093, P. R. China. Hauptthemen laut MEDLINE: Doxorubicin, Polyglutamic Acid, Camptothecin, Hydrogels. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A dual‐drug‐loaded γ‐polyglutamic acid (γ‐PGA) hydrogel was synthesized, integrating third‐generation dendrimers (G3) as cross‐linkers for the simultaneous encapsulation of hydrophilic doxorubicin (DOX) and hydrophobic camptothecin (CPT). This hydrogel, formed via an efficient EDC/NHS‐mediated reaction, demonstrated a biocompatible, porous, and pH‐responsive network. The hydrophobic core of G3 significantly enhanced CPT loading, while γ‐PGA facilitated effective DOX incorporation. Controlled drug release was observed, with DOX releasing faster in acidic tumor‐like environments, optimizing therapeutic impact at the tumor site. In vitro studies highlighted the hydrogel's high biocompatibility and synergistic anticancer efficacy, reducing CT26 colon cancer cell viability more effectively than single‐drug systems. In vivo experiments confirmed substantial tumor suppression, prolonged survival, and the absence of systemic toxicity in murine models. These results underscore the potential of this dual‐drug delivery platform as a robust, multifunctional system for cancer therapy. The biocompatibility, degradability, and tailored drug release characteristics make this hydrogel a promising candidate for clinical translation, offering a novel solution for enhancing cancer treatment efficacy while minimizing side effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinPolyglutamic AcidCamptothecinHydrogelsDrug CarriersAntineoplastic AgentsAnimalsHydrophobic and Hydrophilic InteractionsMiceCell SurvivalHumansDrug LiberationCell Line, TumorMice, Inbred BALB CCell ProliferationDrug Screening Assays, Antitumor

Stichwörter der Autor:innen

DendrimerDual‐drug hydrogelSustained releaseTumor therapyγ‐polyglutamic acid

Substanzen

DoxorubicinPolyglutamic AcidCamptothecinHydrogelsDrug Carrierspoly(gamma-glutamic acid)Antineoplastic Agents

Autor:innen und Institutionen

  • School of Materials and Chemistry, University of Shanghai for Science and Technology, No. 516 Jungong Road, Shanghai, 200093, P. R. China.
  • Department of Gastroenterology, Ganzhou People's Hospital, No. 16 Meiguan Road, Ganzhou, Jiangxi Province, 341000, P. R. China.

ORCID-Profile: Shige Wang

Zitieren

APA

Jia, X., Wei, Y., Zhang, X., Gu, Q., Liu, Y., Wang, S., & Zhu, C. (2025). Dual‐Drug Loaded γ‐Polyglutamic Acid Hydrogel with Hydrophilic Doxorubicin and Hydrophobic Camptothecin for Enhanced Tumor Therapy. Chemistry – An Asian Journal. https://doi.org/10.1002/asia.202500058

Vancouver

Jia X, Wei Y, Zhang X, Gu Q, Liu Y, Wang S, et al. Dual‐Drug Loaded γ‐Polyglutamic Acid Hydrogel with Hydrophilic Doxorubicin and Hydrophobic Camptothecin for Enhanced Tumor Therapy. Chemistry – An Asian Journal. 2025. doi:10.1002/asia.202500058

BibTeX
@article{Jia2025,
  author = {Jia, Xiaoqing and Wei, Yingfeng and Zhang, Xinyuan and Gu, Qiuping and Liu, Youshun and Wang, Shige and Zhu, Chunping},
  title = {Dual‐Drug Loaded γ‐Polyglutamic Acid Hydrogel with Hydrophilic Doxorubicin and Hydrophobic Camptothecin for Enhanced Tumor Therapy},
  journal = {Chemistry – An Asian Journal},
  year = {2025},
  doi = {10.1002/asia.202500058}
}
Kostenlos starten →